April 30, 2020 / 1:36 PM / a month ago

BRIEF-FDA's Hahn Says Moving At "Lightning Speed" To Review Data On Gilead's Coronavirus Drug - Bloomberg

April 30 (Reuters) -

* U.S. FDA COMMISSIONER HAHN SAYS MOVING AT “LIGHTNING SPEED” TO REVIEW DATA ON GILEAD’S EXPERIMENTAL COVID-19 TREATMENT REMDESIVIR - BLOOMBERG

* U.S. FDA COMMISSIONER HAHN SAYS WANT TO LOOK AT TOTALITY OF DATA TO MAKE SURE GILEAD’S REMDESIVIR IS TARGETED TO THE RIGHT PATIENTS - BLOOMBERG

* FDA'S HAHN DECLINED TO OFFER TIMELINE FOR ALLOWING REMDESIVIR TO REACH MARKET; SAID “SEVERAL DIFFERENT PATHWAYS” AVAILABLE FOR REVIEW - BLOOMBERG Source text : bloom.bg/3aQ8imz Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below